Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through September 2021, as compared to prior period baseline mortality results. This new report is an update to the survey report released in July 2021, which contained data through March 2021.

Description: How do unpredictable short-term mortality shocks due to the Coronavirus impact assumptions for pension valuations? What impact does this have in reviewing a plan's experience and can an actuary justify making adjustments? What portions of the population were most impacted by COVID-19? Find out all this and more during this discussion. This webcast will cover: Current research relating to COVID-19 mortality statistics The MP-2020 improvement scale and the MIM-2021 framework Perspectives on emerging longevity trends

Description: With mortality rates significantly higher in 2020 and 2021 due to the COVID-19 pandemic, actuaries that rely on historical experience cannot properly craft assumptions about the future due to the recent excess deaths. This webcast focuses on the practicality of using pandemic mortality experience, as well as how to overcome the practical challenges of that data implementation. Explore an overview of different approaches used by institutions in the U.S., Canada and UK and an observation of industry survey responses. There will also be a comparison to recent SOA expert opinion surveys and short term impacts on the future of U.S. mortality.

Description: Just as the U.S. is dealing with a new surge of COVID-19 hospitalizations and death, the pandemic’s impact on the nation’s mortality rate is generating heightened interest. Two new reports issued from the Society of Actuaries provide important insights.

Description: In the first part of this series, the presenters will provide the results of a recent SOA multi-country survey on mortality improvement practices of life insurance companies. In the second part of this session, they will discuss the issues and solutions related to the development of the most recent RPEC mortality improvement assumptions.

Description: The purpose of this survey is to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, as compared to prior period baseline mortality results. The datasets for this report encompass all Group Term Life claims reported to participating carriers as of August 31, 2020. The Committee is grateful that 20 of the top 21 U.S. Group Term Life insurers are participating in this survey, with market share representing roughly 90% of the industry.

Description: The VBT Analysis Subgroup (“Subgroup”) of the Joint Academy Life Experience Committee and SOA Preferred Mortality Oversight Group (“Joint Committee”) recommends the approach documented in this report for determining when there is sufficient change in the emerging actual mortality experience relative to the current VBT to warrant changes to the table.

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through September 2021, as compared to prior period baseline mortality results. This new report is an update to the survey report released in July 2021, which contained data through March 2021.

Description: The VBT Analysis Subgroup of the Joint Academy Life Experience Committee and SOA Preferred Mortality Oversight Group recommends the approach documented in this report for determining when there is sufficient change in the emerging actual mortality experience relative to the current VBT to warrant changes to the table.

Description: Dive into the released enhancements of MIM-2021, including a run through of its purpose and evolution, during this webcast. The Mortality and Longevity Strategic Research Program plans to release these updates in October. You will leave this webcast with an understanding of how to create a mortality improvement scale using the necessary steps and tools. Learn how to use MIM-2021 through instruction and demonstration that will properly prepare you to utilize this tool. There will be time for questions where you can ask about the projection process or provide feedback.